Key Person Risk in Private Equity: What LP Agreements Actually Protect You From

    TL;DR 97% of private equity LPAs automatically suspend the investment period when a key person event occurs, but the strength of that protection depends entirely on how the provision is drafted

    ByJeff Barnes, MBA
    ·11 min read
    Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation
    Key Person Risk in Private Equity: What LP Agreements Actually Protect You From

    TL;DR

    • 97% of private equity LPAs automatically suspend the investment period when a key person event occurs, but the strength of that protection depends entirely on how the provision is drafted before you sign.
    • The average suspension runs 170 days. If the event goes unresolved, 92% of fund structures trigger automatic termination of the investment period, leaving you with a changed team managing capital you cannot exit.
    • Before you commit, verify the named key persons actually run the portfolio, confirm the cure period is 90 to 180 days with real LPAC rights, and demand a management fee reduction to 50 to 75% during any suspension.

    Private equity fund investors tend to focus their due diligence on strategy, track record, and fee structure. The key person provision gets treated as boilerplate. That is a mistake. ILPA Principles 3.0, the authoritative LP governance standard published in 2019, dedicates specific guidance to key person provisions precisely because weak drafting converts a powerful protection into a formality. The difference between a well-drafted provision and a poorly negotiated one is the difference between having a real exit lever when the team changes and being a passive capital provider with no recourse.

    Key person risk is not theoretical. Investment teams break apart. Founders retire. The lead partner who sourced the fund's best deals leaves to start a competing vehicle. In each scenario, your capital is already deployed or committed, your lock-up is years long, and your only contractual protection is whatever language you agreed to at closing.

    What Key Person Provisions Actually Do

    A key person provision designates specific named individuals in the Limited Partnership Agreement as essential to the fund's investment strategy. These are not honorary titles. They are the people whose continued active involvement is the contractual basis for the fund's ability to deploy your capital.

    When a defined number of those individuals depart or fail to dedicate the required percentage of their professional time to the fund, a "key person event" is triggered. The immediate, automatic consequence is suspension of the investment period. The fund cannot make new investments. Capital calls for new deals stop. The GP cannot commit your money to new transactions while the event is unresolved.

    Resolution takes one of three forms: an LP or LP Advisory Committee (LPAC) vote to reinstate the investment period, appointment of a GP-proposed replacement that meets defined criteria, or expiration of the suspension period without resolution. That last outcome is what happens in 92% of fund structures when the GP cannot fix the problem, per Goodwin Law's 2024 analysis of their private investment fund terms database. The investment period terminates automatically. The fund moves into harvest mode with whatever team remains.

    Clawback of prior capital deployment is not a standard key person remedy. The provision stops further deployment. If the GP deployed 60% of your committed capital before the key person event, that 60% stays in the portfolio under whatever team is left. The suspension mechanism only protects capital that has not yet been called.

    The Trigger: What Counts as a Departure

    The trigger language in your LPA is where most key person provisions fail. Two structural problems appear repeatedly: who gets named, and what counts as a departure.

    On the naming question, GPs often list senior firm partners who are nominally attached to the fund but not actually running the portfolio. A founding partner who sits on the investment committee but delegates sourcing and monitoring to junior professionals gets named as a key person, giving the GP flexibility to replace the actual working team without triggering the provision. You need to verify that the named key persons are the individuals making investment decisions and managing portfolio companies day to day, not the founders whose names are on the door.

    On departure definition, watch for provisions that define the term narrowly. Some LPAs require formal resignation or termination to trigger the clause. A key person redeployed to a successor fund or removed from the investment committee may not trigger a provision that only counts formal employment separation. ILPA 3.0 recommends that trigger structures include time-commitment thresholds, typically 80% or more of professional time devoted to the fund. If that threshold is breached, the provision triggers regardless of whether the person has formally resigned.

    The most common trigger structure is "departure of X of Y named persons." For a diversified senior team, 2 of 4 or 2 of 5 is standard. For a boutique fund where one individual is the investment thesis, the only defensible threshold is 1 of 1. Preqin's Term Intelligence data from 2026 confirms that 97% of PE fund LPAs include automatic suspension upon a key person event, but the data cannot tell you whether the trigger thresholds in those LPAs are meaningful. That part requires reading the document.

    The Cure Period and Your Rights as an LP

    Once a key person event is triggered, the GP enters a cure period, a window during which it can propose a resolution without the investment period terminating automatically. The average suspension duration in private equity is 170 days, compared to 141 days in real estate funds and 184 days in infrastructure, per Preqin's 2026 data. That 170-day window is your primary leverage period, and it is the phase where your LPA provisions either work or do not.

    During the cure period, you need the following rights in writing before you commit capital.

    Immediate notification. The GP must inform LPs in writing within 2 to 5 business days of a key person event, not at the next quarterly report. ILPA 3.0 is explicit: notification must happen promptly, not at the next scheduled reporting period.

    LPAC consultation rights. The LP Advisory Committee must have formal rights to consult with the GP during the cure period, including access to information about proposed replacements and current portfolio status. Without LPAC consultation rights during suspension, you are operating blind during the most critical governance window the provision creates.

    Management fee reduction. Many LPs negotiate a fee reduction to 50 to 75% of the standard management fee during suspension. If the GP cannot make new investments, the full fee is not justified. This is negotiable at closing, rarely offered voluntarily by GPs, and almost never renegotiated after the fact.

    LP approval for reinstatement. For 62% of funds, reinstating the investment period after a key person event requires majority LP interest or LPAC approval, per Preqin. The remaining 38% use alternative thresholds or hybrid mechanisms. You want majority LP interest or a supermajority (66 to 75%) for reinstatement, not GP unilateral authority. If the GP can appoint a replacement and restart the investment period without LP approval, the suspension mechanism has no real teeth.

    If the cure period expires without resolution, the investment period terminates. The fund moves to harvest mode. You are now waiting for the existing portfolio to be realized by whoever remains. This is how you get trapped: committed capital, no new deal flow, and a team you did not evaluate managing assets you cannot exit.

    Named Case Studies: KKR Succession and the Sequoia Restructure

    Two major succession events illustrate very different approaches, and neither is directly replicable for most fund-level LPs.

    KKR's Sunset Date. In October 2021, KKR appointed Joe Bae and Scott Nuttall as Co-CEOs while co-founders Henry Kravis and George Roberts became Executive Co-Chairmen. The governance restructuring included a contractually defined "Sunset Date" set at the earlier of December 31, 2026, or six months after the death or permanent disability of both co-founders. At that point, founder control via Series I Preferred Stock and KKR Management LLP is eliminated and voting rights shift to one-share-one-vote. This is documented in KKR's SEC filings from the 2021 reorganization.

    What makes KKR's approach notable is the contractual specificity: a defined date, a defined trigger event, and a defined governance outcome. LPs in KKR funds benefit from public company disclosure obligations that supplement fund-level governance. That is an advantage of investing with publicly traded GPs. The limitation is that public company governance and fund-level LP rights are not the same thing. Blackstone's annual 10-K explicitly lists loss of co-founder Steve Schwarzman as a risk factor, but that disclosure does not give fund-level LPs any contractual remedy if Schwarzman departs a specific fund.

    Sequoia's Structural Change. Sequoia Capital's 2022 transition combined a leadership change with a fund structure change. Doug Leone stepped down as global managing partner in favor of Roelof Botha, effective July 5, 2022. This was Sequoia's fourth documented generational leadership transfer: Don Valentine to Leone and Michael Moritz in 1997, Moritz stepping back in 2012, and Leone to Botha in 2022. Simultaneously, Sequoia replaced its traditional 10-year closed-end fund model with a permanent open-ended Sequoia Capital Fund feeding into closed-end sub-funds.

    The structural shift to an evergreen vehicle is material for LPs. Open-ended funds change the liquidity profile and governance dynamics in ways that traditional key person provisions do not fully address. A key person provision in a 10-year closed-end fund has a defined horizon. In an evergreen structure, the fund has no end date, which means the GP's incentive to resolve a suspension operates differently. If you are investing in an evergreen vehicle, verify that the key person provisions explicitly address the open-ended structure and that suspension and wind-down rights are adapted accordingly.

    What ILPA's 3.0 Principles Say You Should Demand

    ILPA Principles 3.0 is the baseline standard for LP governance rights. It is not legally binding, but it is the document you cite in negotiations when a GP pushes back on a provision you are requesting.

    Named key persons must be the individuals who will actually determine investment outcomes for the current fund. Founders who have reduced their operational involvement should not be listed as key persons unless they are genuinely active in fund management. Mid-fund changes to key person provisions should require majority LP interest approval.

    The GP must notify LPs immediately when a key person event occurs. During any suspension, the GP must discuss the full ramifications with the LPAC, including proposed resolution paths and portfolio status. LPs should also have explicit wind-down rights if no resolution is reached within the cure period, specifically the right to elect orderly liquidation rather than continued management by a materially changed team. This is a negotiated right, not a default.

    ILPA also recommends tying GP removal rights for cause to key person events where the GP acts in bad faith or fails to meet notification obligations. Concealment or delayed notification should give LPs the right to remove the GP for cause, not merely trigger a suspension.

    Red Flags in the LPA You Must Catch Before Committing

    The following provisions signal materially weaker protection than ILPA 3.0 recommends. Each is negotiable before closing. None is negotiable after.

    Key persons are firm founders, not fund managers. If the named key persons are executive chairs or firm-level founders not actively managing the current fund's portfolio, the provision is cosmetic. Push for the actual portfolio managers by name.

    No time-commitment threshold. A provision that only triggers on formal employment separation does not protect you against constructive departure. Require a time-commitment threshold of 80% of professional time dedicated to the fund as part of the trigger definition.

    Notification within 30 days or "promptly." Without a defined window, "promptly" can mean a month. Push for 2 to 5 business days. A 30-day notification window gives the GP a month to manage the narrative before you know there is a problem.

    GP-controlled reinstatement. If the GP can reinstate the investment period by appointing a replacement without LP or LPAC approval, the suspension mechanism is controlled by the party with the conflict of interest. Require LP supermajority approval (66 to 75%) for reinstatement.

    No fee reduction during suspension. Full management fees during a suspension period, when no new investments are being made, is a misalignment of incentives. Negotiate a reduction to 50 to 75% of the standard fee. It is standard in well-negotiated LPAs.

    No prohibition on successor fund fundraising. A GP experiencing a key person event should not be raising a new fund simultaneously. Without this restriction, the GP has incentive to resolve the event on paper rather than in substance. Demand an explicit prohibition during any suspension period.

    Review the SEC's 2014 investment management guidance on PE fund disclosure and the GP's Form ADV filing as part of your diligence. For boutique managers, the ADV often names the single key person explicitly and discloses that their departure would likely result in fund dissolution. That language is a diligence signal. If one person is the fund, your LPA must reflect it with a 1-of-1 trigger and no threshold ambiguity.

    Key person provisions have real teeth when drafted correctly. 97% of LPAs include automatic suspension, 92% terminate the investment period if the event goes unresolved, and the average suspension window gives you 170 days to exercise your rights. The problem is not the mechanism. The problem is that most LPs sign LPAs with trigger language designed by the GP's counsel to give the GP maximum flexibility. Read the provision. Name the right people. Demand the rights ILPA says you should have. Do that before you sign.

    Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    J

    About the Author

    Jeff Barnes, MBA